Skip to main content
WOOJUNG BIO, Inc. logo

WOOJUNG BIO, Inc. — Investor Relations & Filings

Ticker · 215380 ISIN · KR7215380007 KO Professional, scientific and technical activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country KR South Korea
Listing KO 215380

About WOOJUNG BIO, Inc.

https://www.woojungbio.kr/eng.php

WOOJUNG BIO, Inc. is a bio-infrastructure company providing an integrated platform for research and development in the life sciences. The company's core activities are structured around three main pillars. First, it offers comprehensive pre-clinical Contract Research Organization (CRO) services, including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its advanced animal laboratory facilities. Second, it specializes in the engineering and construction of modernized research environments, offering complete solutions for building and managing smart laboratories, animal rooms, and GMP-compliant clean rooms. Third, through its 'WOOJUNG BIO Cluster' open innovation platform, it provides R&D infrastructure, incubation, and acceleration support for bio-ventures and startups, aiming to foster the new drug development ecosystem and help transform innovative ideas into therapies.

Recent filings

Filing Released Lang Actions
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Regulatory Filings Classification · 85% confidence The document is a Korean statutory disclosure entitled "기업집단현황공시" (Business Group Status Disclosure) filed annually under Korean fair trade law. It provides detailed corporate group structure, financials, executive/board composition, and intra-group transactions. This is a compliance/regulatory announcement rather than a full annual or interim financial report, investor presentation, or transaction filing. It falls under general regulatory filings.
2026-06-01 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 85% confidence The document is a brief regulatory announcement in Korean setting the record date (주주명부폐쇄기간 또는 기준일 설정) for determining eligible shareholders for an upcoming shareholder meeting. It contains no financial statements or dividend details; it is not a full report but a routine compliance notice. This fits the catch-all “Regulatory Filings” category (RNS).
2026-05-29 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a formal notice convening an extraordinary general meeting of shareholders, including the date, record date, agenda items (amendment of articles, director nomination, retirement pay regulation changes), and detailed proposal descriptions. It is not the meeting minutes or results but is sent to shareholders to inform them of proposals and solicit their votes. Therefore, it corresponds to a Proxy Solicitation & Information Statement.
2026-05-29 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is a Korean "분기보고서 (quarterly report)" covering the fiscal period 2026-01-01 to 2026-03-31, entitled “제12기 분기보고서.” It contains detailed financial and corporate information (company overview, capital changes, share data, etc.) rather than merely announcing the publication of a report. It clearly constitutes the actual interim/quarterly financial report itself. Q1 2026
2026-05-15 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 94% confidence The document is titled “주식등의 대량보유상황보고서(일반)” and contains detailed tables of shareholdings, percentages, acquisition dates, and correction details. It is a regulatory filing to notify a change in significant share ownership (including thresholds and management control intent). This matches the Major Shareholding Notification category.
2026-04-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 90% confidence The document is a "주식등의 대량보유상황보고서(일반)" (“Report on Large Shareholding”), detailing a substantial share position in 우정바이오 by 콜마홀딩스. It includes report dates, share counts, percentages, contractual details, and legal references under the Capital Markets Act – all hallmarks of a major shareholding notification rather than an annual or interim report, earnings release, or management announcement. This aligns exactly with the Major Shareholding Notification category (MRQ).
2026-04-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.